11/19
08:00 am
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/13
04:01 pm
vxrt
Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results
High
Report
Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results
11/7
08:00 am
vxrt
Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13
Low
Report
Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13
10/24
08:00 am
vxrt
Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024
Low
Report
Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024
10/15
08:00 am
vxrt
Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need
Low
Report
Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need
10/2
10:23 am
vxrt
Dr. Wouter Latour Joins PharmaJet as Chief Executive Officer [Yahoo! Finance]
Low
Report
Dr. Wouter Latour Joins PharmaJet as Chief Executive Officer [Yahoo! Finance]
9/30
04:25 pm
vxrt
Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate [Yahoo! Finance]
Medium
Report
Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate [Yahoo! Finance]
9/30
04:16 pm
vxrt
C$ hits 6-day low on Powell remarks but posts quarterly gain [Yahoo! Finance Canada]
Medium
Report
C$ hits 6-day low on Powell remarks but posts quarterly gain [Yahoo! Finance Canada]
9/30
04:12 pm
vxrt
Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
Low
Report
Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
8/30
08:00 am
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
8/28
08:00 am
vxrt
Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical Dysplasia
Medium
Report
Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical Dysplasia